Renal Sympathetic Denervation in the Management of Treatment-Resistant Hypertension




4.

DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75–197.PubMed


5.

DiBona GF. Sympathetic nervous system influences on the kidney: role in hypertension. Am J Hypertens. 1989;2:119S–24.PubMed


6.

Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol. 1983;245:F1–14.PubMed


7.

DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol. 2010;298:R245–53.


8.

Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25:878–82.PubMedCrossRef


9.

Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974–9.PubMedCrossRef


10.

Converse Jr RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912–8.PubMedCrossRef


11.

Chapleau M. Arterial baroreflexes. In: Hypertension primer: the essentials of high blood pressure. 2nd ed. London: Lippincott Williams & Wilkins; 1999. p. 83.


12.

Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc. 1953;152:1501–4.PubMedCrossRef
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 10, 2016 | Posted by in CARDIOLOGY | Comments Off on Renal Sympathetic Denervation in the Management of Treatment-Resistant Hypertension

Full access? Get Clinical Tree

Get Clinical Tree app for offline access